In this series,
The treatment of Graves' disease with radioiodine (131I) has been widely accepted for more than forty years and has been used safely even in children, adolescents and young woman (Graham & Burman 1986; Hamburger 1986 
Patients
From October 1984 to March 1988, twentyseven patients with Graves' disease were treated with radioiodine in our clinic.
However, of these patients nine were excluded from the study for the following reasons: three were treated too recently to be included in the study, three were treated according to a different dosage protocol, and three had previous radioiodine therapy for hyperthyroidism.
The group studied consisted of the remaining eighteen patients. Fourteen of these eighteen patients had previously been treated with antithyroid drugs for one to three weeks, and all of them had been allergic to the drugs and had discontinued them more than 1 month before the radioiodine therapy.
One patient had previous surgical treatment for hyperthyroidism.
Fifteen of the eighteen patients (83%) were women. The patients' ages ranged from 26 to 67 with a mean of 48 years (Table 1 ). All patients were hyperthyroid at the time of the administration of radioiodine.
Radioiodine
Therapy and Follow-up The therapeutic dose of radioiodine (131I) was based on the weight of the thyroid gland, the 24-hour radioiodine uptake and the effective half-life of radioiodine in the thyroid gland. The weight of the thyroid gland was determined 
Discussion
The estimation of the weight of the thyroid gland by palpation and scintigraphy was inaccurate. Soley et al. (1948) reported that they estimated the thyroid size in patients prior to thyroidectomies by palpation and could come within 10% of the actual weight in only a fourth of the subjects. Koyanagi et al. (1984) reported that the gland size determined by scintigraphy was underestimated when its actual weight was more than sixty grams, but overestimated when less than sixty grams. Therefore, the new high resolutional ultrasonic scanner we have developed (Yokohama et al., 1986 ) was introduced to radioiodine therapy of Graves' disease in this study. In our previous study (Yokohama et al., 1986) , the estimated volumes of the thyroids obtained with this new scanner were closely correlated with the actual weights at operation (correlation coefficient: 0.98 in Graves' disease; 0.99 in thyroid adenoma).
As a result, 66.7% of our patients became euthyroid, 27.8% remained hyperthyroid and 5.6% became hypothyroid at one year after treatment. The results in the previous studies have varied from 31 to 79% (Werner et al., 1948 ; Cassidy waltes 1956; Franco & Quina 1956; BlomSmith & Wilson 1967; Rapoport et al., 1973; Cevallos et al., 1974; Reudebush et al., 1977; Sridama et al., 1984) . In the analysis of various factors which may be related to the effect of radioiodine therapy in this study, a significant difference was observed in the gland size in hyperthyroid and euthyroid groups, and the incidence of euthyroidism was as high as 80% in patients with smaller glands but was extremely low in those with larger glands, indicating that a larger thyroid gland requires a larger radioiodine dose per gram of tissue than a smaller gland. Similar evidence has already been provided in many other reports (Werner et al., 1948; Balls et al., 1955; Goolden & Fraser 1969; Roudebush et al., 1977; Sridama et al., 1984) , i n which, however, the gland size was estimated by palpation or scintigraphy. Therefore, it may be proposed that, to be satisfactory, the radiation dose should be graded according to the gland size even when the gland size is accurately estimated by ultrasound. However, many other factors including inhomogeneity of iodine distribution in the thyroid, unequal sensitivity of the thyroid to the irradiation, radioiodine uptake, duration of disease and initial free thyroxine index may also affect it (Werner et al., 1948; Segal et al., 1961; Roudebush et al., 1977; Sridama et al., 1984) . We believe that an accurate calculated radioiodine dose based on various factors must give a more predictable response than an arbitrary and empirical one.
The cumulative incidence of late hypothyroidism in our patients cannot be estimated at this stage, but will probably rise to the same level as those in the previous reports since the annual incidence of hypothyroidism did not different among alternative protocols (Hagen et al., 1967; Smith & Wilson 1967; Glennon et al., 1972; Cevallos et al., 1974) . However, in the case of patients with allergic reactions to antithyroid drugs, as in our report, a definite effect within a short period is necessary even at the cost of a high incidence of late hypothyroidism.
